Genitourinary MDC

Patients diagnosed with prostate cancer, testicular cancer, kidney cancer or bladder cancers  receive treatment through the genitourinary (GU) multidisciplinary (MDC) clinic at KHCC.
Patients are usually referred through the KHCC screening clinic, via direct referral from other hospitals or from abroad.
Accepted patients must have clinical evaluations performed including lab and blood tests, CTs, MRIs and ultrasounds in order to determine the stage of the disease. Biopsies may also be needed. The treatment depends on the disease, stage, and state of the patient but usually comprises of chemotherapy, radiotherapy, surgery or a combination of all three.
The patient’s case is presented to the rest of the team and their pathology slides and radiology images are extensively reviewed. Treatment options are then discussed and relayed to the patient by the attending physician. Patients who are potential candidates for radiation therapy or chemo-radiation are seen and examined by a medical oncologist and radiation oncologist for final disposition and discussion of treatment. Patients who are candidates for surgery are seen by a surgeon.
Who’s on the team?
Dr. Naeem Farah – Head of GU MDC
Dr. Faisal Badainah
Dr. Rami Ghanem
Dr. Iyad Saadi
The team meets weekly to review all the cases on the MDC list
Ancillary and patient support services
The GU team works in close cooperation with the pain management department, physical therapists, nutritionists, and psychosocial services at KHCC in order to provide patients with the most comprehensive care possible.